Dealmaking In A Downmarket

New research from Corporate Board Member and Shearman & Sterling asked 250 public company directors to weigh in on Covid-19-fueled activism, mergers and takeovers.

Pulling The Trigger On M&A

M&A lawyers share considerations for pursuing deals and seizing buy and sell opportunities post-Covid.

Proactively Adopting A Poison Pill In Response To The COVID-19 Crisis

Is your board considering whether to implement defensive measures to combat near-term coercive or abusive takeover? Read this.

Creating Shareholder Value Through M&A—And Beyond

Most acquisitions by public companies fail to create long-term value for their shareholders. However, a few companies have demonstrated the ability to consistently generate shareholder value through inorganic investments. What distinguishes these companies is...

How Boards Can Navigate the Overcomplicated and Undervalued M&A Landscape

In a sluggish market, opportunities for synergy abound. But if you don't want your deal to fail in execution—like 80% of M&A—follow these six steps.

M&A, Valuations and Activism: Board Lessons From 2008

The causes are different, but lessons in the context of M&A and activism abound from the 2008 market collapse and the challenging environment that followed.

Corporate Board Member Institute

The leading continuing education program for public company boards.


How To Onboard A New Director

Boards must be prepared to onboard new directors and facilitate a process that allows them to hit the ground running.

Guide To Board Assessments

Engaging a useful, annual self-assessment is fundamental to governance excellence. Stakeholders expect it, and disclosure of it evidences a board’s effectiveness and commitment to its role.

Committee Briefings: Top Considerations for 2020

Investor expectations, new disclosure requirements, ESG, current and future trends–your committee agendas are filling up.